Benchling’s Post

View organization page for Benchling, graphic

44,483 followers

What’s the major limiting factor for #AI/#ML today? And what’s the solution? The Financial Times gathered industry icons Roger M. Perlmutter (CEO, Eikon Therapeutics), Bari Kowal (SVP of Development Operations, Regeneron), and Thomas Miller (CEO and co-founder, Iambic Therapeutics), together with Benchling CEO Sajith Wickramasekara to share their predictions for the future of AI — and insights on how #pharma will get there. Check out their top takeaways from #FTPharma: https://lnkd.in/eSTGFY7g

4 key insights from pharma leaders on the future of AI

4 key insights from pharma leaders on the future of AI

benchling.com

To view or add a comment, sign in

Explore topics